Zobrazeno 1 - 10
of 65
pro vyhledávání: ''
Publikováno v:
Cancer Epidemiol
BACKGROUND. Over the past 20 years, many novel agents and treatment regimens have been developed to treat mantle cell lymphoma (MCL). This study aimed to determine the impact of these new regimens on the survival of MCL patients from 1995 to 2013. ME
Autor:
Colonna, M., Boussari, O., Cowppli-Bony, A., Delafosse, P., Romain, G., Grosclaude, P., Jooste, V., Cancer Registries (FRANCIM)., French Network of
Publikováno v:
Cancer Epidemiology, Biomarkers and Prevention
Cancer Epidemiology, Biomarkers and Prevention, American Association for Cancer Research, 2018, 56, pp.97-105. ⟨10.1016/j.canep.2018.08.001⟩
Cancer Epidemiology, Biomarkers and Prevention, American Association for Cancer Research, 2018, 56, pp.97-105. ⟨10.1016/j.canep.2018.08.001⟩
IF 2.888 (2017); International audience; BackgroundThis study analyzes time trends in cancer prevalence in France and provides short-term projections up to the year 2017. The 15-year prevalence for 24 cancers was estimated from the French cancer regi
Publikováno v:
Næser, E, Møller, H, Fredberg, U & Vedsted, P 2018, ' Mortality of patients examined at a diagnostic centre: A matched cohort study ', Cancer epidemiology, vol. 55, pp. 130-135 . https://doi.org/10.1016/j.canep.2018.06.008
Background ‘Diagnostic Centres’ has been established to provide a diagnostic pathway for patients with non-specific, serious symptoms that could be cancer. As little is known about the prognosis, we aimed to 1) analyse mortality of patients exami
Publikováno v:
Cancer Epidemiology. 52:91-98
Low socioeconomic status and poor education elevate the risk of developing esophageal- and junctional cancer. High education level also increases survival after curative surgery. The present study aimed to investigate associations, if any, between pa
Subsite- and stage-specific colorectal cancer trends in Estonia prior to implementation of screening
Publikováno v:
Cancer Epidemiology. 52:112-119
Background The occurrence of colorectal cancer (CRC) in Estonia has been characterised by increasing incidence, low survival and no screening. The study aimed to examine long-term incidence and survival trends of CRC in Estonia with specific focus on
Autor:
Sonia del Barco, Marta Solans, Rafael Marcos-Gragera, Aina Roca-Barceló, Aurora Astudillo, Rafael Fuentes-Raspall, Mª Carme Carmona-Garcia, L. Vilardell, Raquel Comas, Montse Puigdemont, Adelaida Garcia-Velasco
Publikováno v:
Cancer Epidemiology. 50:1-8
Background Systematic registration of non-malignant central nervous system (CNS) tumors is a rare practice among European cancer registries. Thus, the real burden of all CNS tumors across Europe is underestimated. The Girona Cancer Registry provides
Autor:
Helen M. Fenlon, Margaret Walshe, Marie Boyle, Jason Trikovic, J Leyden, Zita Galvin, Michael P. Farrell, Ion Cretu, Sinéad Foy, Loretta O’Brien, Victoria Swan, Robert Moran, David J. Gallagher, Padraic MacMathuna, Niall Mulligan
Publikováno v:
Cancer Epidemiology. 50:30-38
We present the 15-year experience of a family colorectal cancer screening service in Ireland with emphasis on real life experience and outcomes.Questionnaires were used to assess family cancer history and assign patients to risk categories; 'Moderate
Autor:
Maria Angeles Sala-Gonzalez, Javier Mar, Ramon Clèries, Maria Luisa Iruretagoiena, Oliver Ibarrondo, Ibone Elejoste, Arantzazu Arrospide, Alfredo Paredes
Publikováno v:
Cancer epidemiology. 65
Introduction The objective of this study was to analyze the survival of patients with lung cancer by TNM stage in the 4-year periods 2003–2006, 2007–2010 and 2011–2014, treated in the Basque Health Service, and to compare this with survival in
Autor:
Ralf Ketter, Joachim Oertel, Andreas von Deimling, Steffi Urbschat, Felix Sahm, Daniel Zampella, Bernd Holleczek
Publikováno v:
Cancer epidemiology. 62
Background Meningiomas are mostly benign tumors that originate from the coverings of the brain and spinal cord. Compared to malignant glial tumors, meningiomas are relatively understudied with regard to their risk factors and epidemiology. In particu
Autor:
Henrik Toft Sørensen, Lars Pedersen, Johan Frederik Håkonsen Arendt, Dóra Körmendiné Farkas, Ebba Nexo
Publikováno v:
Arendt, J F H, Farkas, D K, Pedersen, L, Nexo, E & Sørensen, H T 2016, ' Elevated plasma vitamin B12 levels and cancer prognosis : A population-based cohort study ' Cancer epidemiology, vol. 40, pp. 158-65 . https://doi.org/10.1016/j.canep.2015.12.007
Background Elevated plasma vitamin B12 levels (cobalamin, Cbl) are associated with increased short-term cancer risk among patients referred for this laboratory measurement. We aimed to assess prognosis in cancer patients with elevated plasma Cbl. Met